PFE vs SNDK: Which Is the Better Buy?
Side-by-side comparison of Pfizer Inc. and Sandisk Corporation — fair value, conviction, valuation metrics, and QuantHub research signals.
Updated 2026-08-06.
Pfizer Inc. · Healthcare
$25.22
+2.8% upside to fair value
Grade B
VS
Sandisk Corporation · Technology
$1,350.50
+22.2% upside to fair value
Med Conviction
Grade B-
QuantHub Verdict
SNDK has more upside to fair value
(+22.2%).
SNDK trades at a lower forward P/E
(6.6x).
These are model outputs — not personalized investment advice.
See all research →
Valuation & Fundamentals
| Metric |
PFE |
SNDK |
| Current Price |
$25.22 |
$1,350.50 |
| Fair Value Estimate |
$25.92 |
$1,650.00 |
| Upside to Fair Value |
+2.8%
|
+22.2%
|
| Market Cap |
$143.7B |
$200.0B |
| Forward P/E |
19.2x
|
6.6x
|
| EV / EBITDA |
12.3x
|
25.0x
|
| Price / Sales |
2.3x
|
9.8x
|
| Price / FCF |
15.2x
|
17.3x
|
| Revenue Growth YoY |
+5.4%
|
+174.0%
|
| Gross Margin |
69.3%
|
71.5%
|
| Operating Margin |
23.4%
|
62.0%
|
| Return on Equity |
8.4%
|
44.0%
|
| Dividend Yield |
0% |
0.0% |
| FCF Yield |
6.6%
|
5.8%
|
| Analyst Consensus |
Hold
|
Buy
|
Investment Thesis
Pfizer Inc. is a leading global biopharmaceutical company with a diversified portfolio dominated by its Biopharma prescription segment, which accounts for over 90% of revenue. The company benefits from a substantial scale, a broad product portfolio including top-selling drugs like Eliquis, Prevnar, and Paxlovid, and a strong manufacturing footprint. However, Pfizer faces challenges from declining…
SanDisk is a pure-play on NAND flash memory, spun out of Western Digital in February 2025, and has become one of the defining beneficiaries of the AI storage supercycle. An acute shortage of high-performance enterprise SSDs for AI training and inference has driven NAND pricing sharply higher, taking gross margin from under 30% in fiscal Q1 to roughly 85% in fiscal Q4 2026 and lifting the stock mo…
Accumulation Zones
| Metric |
PFE |
SNDK |
| Zone Low |
$19.44 |
$1,240.00 |
| Zone High |
$22.03 |
$1,400.00 |
| In Buy Zone? |
No
|
Yes
|